Literature DB >> 9974183

The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs.

S Altuğ1, O Uzun, A T Demiryürek, I Cakici, N Abacioğlu, I Kanzik.   

Abstract

We have investigated the effects of nitric oxide synthase inhibitor (L-NAME), nitric oxide precursor (L-arginine) and nitric oxide donor (sodium nitroprusside) on digoxin-induced arrhythmias both in guinea-pig isolated hearts and in anaesthetised animals. Sodium nitroprusside (0.1 mumol kg-1 min.-1 for 70 min.) caused a marked inhibition in mortality and arrhythmia score but L-NAME (10 mg kg-1) and L-arginine (30 mg kg-1 intravenous bolus followed by 10 mg kg-1 min.-1 for 60 min.) treatments were ineffective in anaesthetised guinea-pigs. None of the drugs markedly affected the time of onset of first arrhythmias or ventricular fibrillation incidence. In isolated heart experiments, nitric oxide generated by either L-arginine (1 mM) or sodium nitroprusside (1 mM) significantly reduced the arrhythmia score whereas L-NAME (1 mM) had no effect. Ventricular fibrillation incidence was totally abolished by sodium nitroprusside and none of the hearts treated with L-arginine had an irreversible ventricular fibrillation. L-NAME decreased ventricular tachycardia duration but increased ventricular fibrillation duration. There were no marked changes in the time of onset of first arrhythmias with these drugs in in vitro experiments. These results suggest that nitric oxide may play a modulatory role in the digoxin-induced arrhythmias in guinea-pigs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9974183     DOI: 10.1111/j.1600-0773.1999.tb02103.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  2 in total

1.  Role of nitric oxide in regulating cardiac electrophysiology.

Authors:  L Wang
Journal:  Exp Clin Cardiol       Date:  2001

2.  Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis.

Authors:  Daniel C Zielinski; Fabian V Filipp; Aarash Bordbar; Kasper Jensen; Jeffrey W Smith; Markus J Herrgard; Monica L Mo; Bernhard O Palsson
Journal:  Nat Commun       Date:  2015-06-09       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.